Hit & Run – Continuous News, Views, and Abuse by the Reason Staff
FDA faces important decisions on regulation of e-cigarettes
July 17, 2013Posted by on
Could the risks be ameliorated by changes in engineering? Regulatory concerns go beyond the chemical background of the product. Even if e-cigarettes are shown to be less toxic than cigarettes, there are social implications to consider, the authors pointed out. The acceptance and prevalence of smoking a hand-held device may promote and renormalize the use of cigarettes, electronic or not. Nonsmokers may start smoking e-cigarettes before moving on to real ones, and the simultaneous use of both products could postpone or entirely hinder a smoker’s quitting efforts. Furthermore, the FDA must decide how marketing should be regulated in the context of potential benefits and population risks.
For the original version including any supplementary images or video, visit http://www.clinicaladvisor.com/fda-faces-important-decisions-on-regulation-of-e-cigarettes/article/303113/